Lamotrigin Atid

Lamotrigine, the active ingredient in Lamotrigin Atid, is an anticonvulsant presented as an oral tablet for oral use. It is used to treat epilepsy, bipolar disorder, and migraine prophylaxis in adult patients. The medication works by stabilizing neuronal membranes and decreasing excessive excitatory neurotransmitter release, helping to control seizure activity and mood swings.

GNH USA supplies Lamotrigin Atid as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company ensures quality assurance through rigorous testing and adheres to global regulatory standards.

Lamotrigine is an anticonvulsant that acts on neuronal excitability in several neurological and psychiatric conditions.

- Epilepsy: reduces seizure frequency and severity, helping patients achieve better seizure control and improve quality of life. - Bipolar disorder: stabilizes mood and prevents manic and depressive episodes, contributing to long‑term mood stability and reduced hospitalization risk. - Migraine prophylaxis: decreases frequency of migraine attacks, leading to fewer headache days and improved daily functioning for patients. - Focal seizures: used as adjunctive therapy to control partial‑onset seizures, enhancing overall seizure management. - Generalized tonic‑clonic seizures: provides adjunctive treatment to reduce seizure occurrence in patients with this seizure type.

Lamotrigine may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Skin rash: mild itching or redness. - Headache: transient headache episodes. - Dizziness: light‑headed sensation. - Nausea: occasional upset stomach. - Blurred vision: temporary visual disturbances.

Serious or Rare Side Effects: - Stevens‑Johnson syndrome: severe skin reaction that can be life‑threatening. - Toxic epidermal necrolysis: extensive skin detachment requiring urgent care. - Aseptic meningitis: inflammation of the meninges without infection. - Blood dyscrasias: rare cases of anemia or leukopenia. - Severe hypersensitivity: multi‑organ allergic reaction.

When prescribing lamotrigine, clinicians should consider several precautionary measures to ensure patient safety.

- Pregnancy: category D, use only if benefits outweigh risks. - Skin reactions: monitor for rash and discontinue if severe. - Drug interactions: adjust dose when co‑administered with enzyme inducers or inhibitors. - Renal/hepatic impairment: use caution and consider dose modification. - Psychiatric monitoring: observe for mood changes or suicidal thoughts. - Store at ambient temperature: keep in the original pack, protect from moisture.

Lamotrigine interacts with several medicines that can alter its plasma concentration or increase the risk of adverse effects.

Major Interactions (Avoid): - Valproic acid: markedly increases lamotrigine levels, risk of toxicity. - Carbamazepine: reduces lamotrigine levels, may diminish efficacy. - Phenobarbital: induces metabolism, lowering lamotrigine concentrations.

Moderate Interactions (Monitor Closely): - Oral contraceptives: increase lamotrigine clearance, may require dose adjustment. - Rifampin: enzyme inducer that lowers lamotrigine levels. - Serotonergic agents: potential for additive central nervous system effects.